Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Infectious Mononucleosis Triggers Generation of IgG Auto-Antibodies against Native Myelin Oligodendrocyte Glycoprotein.
Natalizumab SC Similar to IV Every 4 Weeks for MS
Multiple sclerosis starting before the age of 18 years: the Brazilian experience.
[Remyelination strategy for multiple sclerosis].
T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease.
The PANGAEA study design - a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practice.
Optic neuritis following aseptic meningitis associated with modified measles: a case report.
A tetramethoxychalcone from Chloranthus henryi suppresses lipopolysaccharide-induced inflammatory responses in BV2 microglia.
InMS: Chronic insomnia disorder in multiple sclerosis - a Portuguese multicentre study on prevalence, subtypes, associated factors and impact on quality of life.
Multiple sclerosis masquerading as Alzheimer-type dementia: Clinical, radiological and pathological findings.
Altered cognitive-emotional behavior in early experimental autoimmune encephalitis - Cytokine and hormonal correlates.
Objectification of psychogenic postural instability by trunk sway analysis.
Induction of oligodendrocyte differentiation and in vitro myelination by inhibition of rho-associated kinase.
Anti-inflammatory mechanisms of IFN-γ studied in experimental autoimmune encephalomyelitis reveal neutrophils as a potential target in multiple sclerosis.
Next-Generation Sequencing Identifies MicroRNAs that Associate with Pathogenic Autoimmune Neuroinflammation in Rats.
Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants.
Cerebrospinal fluid neurofilament light chain levels predict visual outcome after optic neuritis.
Actively Induced Experimental Autoimmune Encephalomyelitis in Rats.
Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination.
Determination of Brain Volumes Using Quantitative MR Imaging in Patients with Multiple Sclerosis.
Tumefactive multiple sclerosis and fingolimod: Immunotherapies and unintended consequences.
Quantifying Demyelination in NK venom treated nerve using its electric circuit model.
Circulating Memory T Follicular Helper Cells in Patients with Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders.
[Proportion and significance of CD1d(hi)CD5(+)CD19(+) regulatory B cell in peripheral blood of patients with neuromyelitis optica].
Alternatives for reducing relapse rate when switching from natalizumab to fingolimod in multiple sclerosis.

Pages